QNCX

Conviction 35HealthcareScan · Thu, Jun 25, 2026

Bullish harami

QNCX$0.9715+2.08%

ResistanceSupportVol 14

Vol MA14 383K

Mar 26Apr 14May 1May 19Jun 8Jun 25

Quince Therapeutics, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.quincetx.com ↗

Price0.9715

Change+2.08%

Gap+1.01%

Rel volume0.51×

Avg volume513.88K

Avg $ vol525.94K

SMA 200.9940

SMA 501.14

SMA 2001.54

Price vs 50-14.59%

Price vs 200-37.01%

MA stackbearish

50/200 cross—

Supertrenddown · 1.16

RSI (14)47

MACD hist-0.00

MACD cross—

Stoch %K / %D42 / 33

ADX (14)14

+DI / −DI22 / 18

RSI divergence—

MACD divergence—

ATR %+8.77%

ADR %7.31%

52w high4.40

52w low0.0800

From 52w high-77.92%

Above 52w low+1114.38%

New 52w highNo

SqueezeOff

Bollinger width32.32%

%B0.43

Donchian pos25.18%

Donchian high1.23

Donchian low0.8845

AVWAP (52w high)0.3527

vs AVWAP high+175.43%

AVWAP (52w low)0.2189

vs AVWAP low+343.76%

OBV trendDown

Chaikin MF (20)-0.37

Today vs 20d0.51×

Avg vol (14d)383K

Avg vol (20d)513.88K

Avg $ vol (20d)525.94K

Market cap15.84M

RS 3m (vs SPY)+909.98%

RS 6m (vs SPY)-81.08%

RS line new highNo

Trend template2/8

Technical rank13.2

1 week+7.59%

1 month-19.04%

3 months+852.45%

6 months-73.38%

1 year-33.00%

YTD-67.62%

P/E-0.19

P/B1.01

P/S—

P/FCF-0.38

EPS-1.68

Div yield—

ROE-535.85%

ROA-315.44%

Debt/Eq0.00

Current2.92

EV/EBITDA0.04

Gross margin—

Net margin—

Rev growth—

EPS growth-47.78%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value-2.33M

Revenue—

Net income35.91M

Gross profit—

Free cash flow-41.78M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out16.3M

Employees38

ListedThu, May 9, 2019

Free float46.73M

Float %83.9%

Short interest2.06M

Days to cover0.6d

Short volume41.3%

Squeeze score13 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.59

Last surprise—

Setup gradeD

Conviction35 / 100

Pattern quality—

Tech rank13.2 / 100

Group rank50 / 100

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmBullish harami

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in QNCX

All disclosures →

No recent disclosed trades by Congress in QNCX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in QNCX

No recent insider (Form 4) filings in QNCX. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in QNCX · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.